Safe Orthopedics announces that the Paris court has rendered a favorable judgment in the Neo Medical infringement case

[ad_1]

  • Condemned the counterfeit products of Neo Medical SAS and Neo Medical SA
  • Neo Medical bans the import and sale of its pedicle screw kits in France
  • Destroy the Neo Medical SAS stock of the pedicle screw kit under the control of the bailiff.

Éragny-sur-Oise, France, May 31Yingshi, 2021 at 8:35 am CET – Safe Orthopedics (FR0013467123 – ALSAF) is a company specializing in the design, manufacturing and marketing of ready-to-use technology for back surgery, with a special focus on the treatment of emergency vertebral fractures. It announced its judgment on May 28, 2021 by the Paris Judicial Court The Third Chamber won the Neo Medical infringement case.

Safe Orthopaedics discovered that the French and Swiss Neo Medical companies were importing and selling products on French territory. These products copied the features of a patent claim. Safe Orthopaedics sued Neo Medical in the Paris court for infringement and unfairness. Competition cases.

Excerpt from the judgment:

“On May 28, 2021, the Paris Judicial Court publicly ruled in accordance with the judgment provided by the clerk’s office that the judgment was contradictory and the first instance had:

-Rejected NEO MEDICAL’s request to cancel the infringement seizure report in a medical institution on November 17, 2017

-The revocation request of SAFE ORTHOPEDICS patent items 1 to 13 was rejected

-A statement that NEO MEDICAL has copied SAFE ORTHOPEDICS patent claims 1 to 5, 11 and 13 of its products through importing, distributing and marketing in France, and has committed infringements that harm SAFE ORTHOPAEDICS.

Therefore, the Paris Court of First Instance has:

-NEO MEDICAL is prohibited from importing and selling PEDICLE SCREW KIT products in France and imposes a fine

-Order the destruction of the PEDICLE SCREW KIT products remaining in the NEO MEDICAL SAS premises and impose penalties under the control of the bailiffs,

-Order NEO MEDICAL to communicate certain information in order to determine the exact amount of loss suffered by SAFE ORTHOPEDICS…”

Pierre Dumouchel, Chairman and CEO of Safe Orthopedics, commented: “The Paris court, like the European Patent Office, confirmed the strength of our patents and asked our competitors to withdraw the technology that was deemed counterfeit. We are pleased with this decision, which protects our know-how and our presence in France. The market is estimated to be about 100 million euros. We will continue to protect our innovations, which are the result of the ideas of loyal surgeons, and the financial interests of our shareholders, who recognize our uniqueness and invest in our international expansion “.

About Security Group
Safe Group is a French medical technology group that unites Safe Orthopaedics (the pioneer of ready-to-use technology in spinal pathology) and Safe Medical (formerly LCI Medical), a subcontractor of orthopedic surgical medical equipment. The group has approximately 150 employees.

Safe Orthopedics develops and manufactures kits that combine sterile implants and disposable instruments that surgeons can use at any time. These technologies are part of a minimally invasive approach designed to reduce the risk of contamination and infection, benefit patients, and have a positive impact on length of stay and costs. Protected by 18 patent families, SteriSpineTM value The kit has the CE mark and FDA approval. Safe Orthopedics is headquartered in the Paris region (95610 Eragny sur Oise-France), and has subsidiaries in the United Kingdom, Germany, the United States, and the Lyon region where the manufacturing company is located.
Want more information: www.SafeOrthopaedics.com

Safe Medical (formerly LCI Medical) produces implantable medical devices and ready-to-use instruments. It has an innovation center and two production bases in France and Tunisia, providing numerous industrial services: design, industrialization, machining, finishing and aseptic packaging. With the support of France’s 2020 recovery plan, the company is investing in additive printing and will put this new technology into operation in 2022.
Want more information: www.safemedical.fr

Contact person

Safety Orthopedics

Francois-Henri Reynolds
Chief Financial and Administrative Officer
Phone: +33 (0)1 34 21 50 00
Investor@safeorthopaedics.com

Media relations
Ulysses Communications
Pierre-Louis Germain / +33 (0) 6 64 79 97 61 / plgermain@ulysse-communication.com
Bruno Arab / +33 (0)6 87 88 47 26 / barabian@ulysse-communication.com

[ad_2]

Source link

Recommended For You

About the Author: News Center